Affordable Access

Should we still be doing duplicate immunoassays?

Authors
  • Lester, E
  • Corns, C
Type
Published Article
Journal
Journal of clinical pathology
Publication Date
Sep 01, 1988
Volume
41
Issue
9
Pages
989–991
Identifiers
PMID: 2461391
Source
Medline
License
Unknown

Abstract

To determine whether, with improvements in radioimmunoassay techniques, duplication is still necessary, the differences between duplicate results for a range of assays done routinely over one month were examined retrospectively. Differences over 10% between duplicates were found in 104/779 (13%) of assays for thyroid stimulating hormone, 27/180 (15%) for total thyroxine, 44/378 (12%) for cortisol, 15/355 (4%) for follicular stimulating hormone, 20/356 (6%) for luteinising hormone, and none for alpha fetoprotein (0/256). In only two of 779 patients (0.26%) would the different result of a pair of thyroid stimulating hormone duplicates have led to different courses of action by the laboratory. None of the other differences in any assay would have resulted in a potential misclassification. Although replication of assays will give more correct results by pure scientific criteria, the improvement is rarely clinically important and the financial cost is considerable.

Report this publication

Statistics

Seen <100 times